Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0453 Transporter Info | ||||
Gene Name | SLC6A20 | ||||
Transporter Name | Sodium/imino-acid transporter 1 | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class 1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 4 TF(s) Regulating This DT |
|||||
MNT |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC6A20 gene | [1] | ||||
TF Protein Name |
Max-binding protein MNT | Transcription Factor Info | ||||
Tissue |
Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Max-binding protein MNT (MNT) can directly bind to the SLC6A20 gene, which in turn affects the expression or function of the drug transporter Sodium/imino-acid transporter 1. | |||||
TCF3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC6A20 gene | [2] | ||||
TF Protein Name |
Transcription factor E2-alpha | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2-alpha (TCF3) can directly bind to the SLC6A20 gene, which in turn affects the expression or function of the drug transporter Sodium/imino-acid transporter 1. | |||||
USF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC6A20 gene | [3] | ||||
TF Protein Name |
Upstream stimulatory factor 1 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Brain; Embryo; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Upstream stimulatory factor 1 (USF1) can directly bind to the SLC6A20 gene, which in turn affects the expression or function of the drug transporter Sodium/imino-acid transporter 1. | |||||
USF2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC6A20 gene | [4] | ||||
TF Protein Name |
Upstream stimulatory factor 2 | Transcription Factor Info | ||||
Tissue |
Cervix | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Upstream stimulatory factor 2 (USF2) can directly bind to the SLC6A20 gene, which in turn affects the expression or function of the drug transporter Sodium/imino-acid transporter 1. | |||||
Class 2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
KLF5 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC6A20 gene | [1] | ||||
TF Protein Name |
Krueppel-like factor 5 | Transcription Factor Info | ||||
Tissue |
Colon; Pancreatic ductal; Stomach | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 5 (KLF5) can directly bind to the SLC6A20 gene, which in turn affects the expression or function of the drug transporter Sodium/imino-acid transporter 1. | |||||
Class 3.1: Homeo domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
POU3F4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC6A20 gene in inner ear malformations condition | [5] | ||||
TF Protein Name |
POU domain, class 3, transcription factor 4 | Transcription Factor Info | ||||
Studied Phenotype |
Inner ear malformations [ICD11: LA22.4] | |||||
Tissue |
Ear | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human hearing loss associated with inner ear malformations cell isolates | |||||
Detailed Description |
POU domain class 3 transcription factor 4 (POU3F4) has been reported to activate the transcription of SLC6A20 gene in inner ear malformations condition, which leads to an increased expression of the drug transporter Sodium/imino-acid transporter 1. | |||||
Class 3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
FOXA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC6A20 gene | [3] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-alpha | Transcription Factor Info | ||||
Tissue |
Breast; Embryo; Liver; Lung; Pancreatic ductal; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-alpha (FOXA1) can directly bind to the SLC6A20 gene, which in turn affects the expression or function of the drug transporter Sodium/imino-acid transporter 1. | |||||
Class 6.7: Grainyhead domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
GRHL3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC6A20 gene | [4] | ||||
TF Protein Name |
Grainyhead-like protein 3 homolog | Transcription Factor Info | ||||
Tissue |
Skin | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Grainyhead-like protein 3 homolog (GRHL3) can directly bind to the SLC6A20 gene, which in turn affects the expression or function of the drug transporter Sodium/imino-acid transporter 1. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.